Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties

被引:440
作者
Gifford, JL [1 ]
Hunter, HN [1 ]
Vogel, HJ [1 ]
机构
[1] Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, Calgary, AB T2N 1N4, Canada
关键词
lactoferrin; lactoferricin; antimicrobial; antiviral; antitumor; anti-inflammatory; peptide structure; protein structure;
D O I
10.1007/s00018-005-5373-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The peptide lactoferricin (Lfcin) can be released from the multifunctional protein lactoferrin (LF) through proteolysis by pepsin under acidic conditions, a reaction that occurs naturally in the stomach. Lfcin encompasses a large portion of the functional domain of the intact protein, and in many cases it not only retains the activities of LF but is more active. Lfcin possesses strong antimicrobial and weak antiviral activities, and it also has potent antitumor and immunological properties. This review covers the current state of research in this field, focusing on the many beneficial activities of this peptide. Throughout we will discuss the breadth of Lfcin activity as well as the mechanism of action. Many recent studies have drawn attention to the fact that the main site of action for the peptide may be intracellular. In addition the results of structural and dynamic studies of Lfcin are presented, and the relationship between structure and activity is explored.
引用
收藏
页码:2588 / 2598
页数:11
相关论文
共 81 条
[1]
Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes [J].
Aguilera, O ;
Ostolaza, H ;
Quirós, LM ;
Fierro, JF .
FEBS LETTERS, 1999, 462 (03) :273-277
[2]
Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface [J].
Andersen, JH ;
Jenssen, H ;
Sandvik, K ;
Gutteberg, TJ .
JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (02) :262-271
[3]
Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir [J].
Andersen, JH ;
Jenssen, H ;
Gutteberg, TJ .
ANTIVIRAL RESEARCH, 2003, 58 (03) :209-215
[4]
Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts [J].
Andersen, JH ;
Osbakk, SA ;
Vorland, LH ;
Traavik, T ;
Gutteberg, TJ .
ANTIVIRAL RESEARCH, 2001, 51 (02) :141-149
[5]
Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide [J].
Andrä, J ;
Lohner, K ;
Blondelle, SE ;
Jerala, R ;
Moriyon, I ;
Koch, MHJ ;
Garidel, P ;
Brandenburg, K .
BIOCHEMICAL JOURNAL, 2005, 385 :135-143
[6]
Induction of apoptosis in WEHI 231 cells by cationic liposomes [J].
Aramaki, Y ;
Takano, S ;
Arima, H ;
Tsuchiya, S .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :515-520
[7]
Baker HM, 2000, INT CONGR SER, V1195, P3
[8]
ANTIFUNGAL PROPERTIES OF LACTOFERRICIN-B, A PEPTIDE DERIVED FROM THE N-TERMINAL REGION OF BOVINE LACTOFERRIN [J].
BELLAMY, W ;
YAMAUCHI, K ;
WAKABAYASHI, H ;
TAKASE, M ;
TAKAKURA, N ;
SHIMAMURA, S ;
TOMITA, M .
LETTERS IN APPLIED MICROBIOLOGY, 1994, 18 (04) :230-233
[9]
ANTIBACTERIAL SPECTRUM OF LACTOFERRICIN-B, A POTENT BACTERICIDAL PEPTIDE DERIVED FROM THE N-TERMINAL REGION OF BOVINE LACTOFERRIN [J].
BELLAMY, W ;
TAKASE, M ;
WAKABAYASHI, H ;
KAWASE, K ;
TOMITA, M .
JOURNAL OF APPLIED BACTERIOLOGY, 1992, 73 (06) :472-479
[10]
IDENTIFICATION OF THE BACTERICIDAL DOMAIN OF LACTOFERRIN [J].
BELLAMY, W ;
TAKASE, M ;
YAMAUCHI, K ;
WAKABAYASHI, H ;
KAWASE, K ;
TOMITA, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1121 (1-2) :130-136